Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- What are the benefits and harms of budesonide for induction of remission in Crohn's disease?
- How do the immunosuppressive drugs azathioprine and 6-mercaptopurine compare with placebo or infliximab for inducing remission in people with Crohn's disease?
- How does adalimumab compare with placebo for inducing remission in people with Crohn's disease?
- How does adalimumab compare with placebo for managing Crohn's disease in adults and adolescents?
- What are the benefits and harms of oral 5-aminosalicylic acid for maintenance of medically induced remission in Crohn's disease?
- How does surveillance compare with no surveillance for detecting colon cancer in people with ulcerative colitis or inflammatory bowel disease?
O uso deste conteúdo está sujeito ao nosso aviso legal